DCLS

What DCLS does

DCLS (Diagno Care Life Sciences Pvt. Ltd.) is a Chennai-headquartered, privately held in-vitro diagnostics (IVD) marketing and distribution company serving the Indian market across hematology, urine analysis, biochemistry, critical care, immunoassay, point-of-care testing, and blood banking. The company operates through a 110-distributor network that covers all peripheral regions of India and serves roughly 3,000 customers, including private hospital chains (Apollo, Metro, Hitech, Neuberg, Medall, Bioline, Micro, Premier, Sprint), laboratory chains, government hospitals, and corporate institutions, with 1,500 analyzer installations reported on the company's website.

The product portfolio is built primarily on international OEM partnerships — Boule Medical AB (Swelab, Sweden) for hematology, Snibe (China) for chemiluminescence immunoassay (Maglumi X3/X6/X8), Nova Biomedical for critical care blood gas (Stat Profile Prime CCS/Plus), and Zybio for urine analyzers and POCT — supplemented by indigenously manufactured offerings in ESR (Diagno ESR), biochemistry (DC 300/DC 400, Diagnochem DC/DC7), and complementary POCT. Equipment integrates bidirectionally with Laboratory and Hospital Information Systems via HL7, ASTM, TCP/IP, and POCT01-A2 protocols, and certain products (notably the DC UA 500 urine analyzer) embed computer-vision/AI-based classification. The Stat Profile Prime Plus carries CE and FDA registration, supporting premium positioning in critical care.

DCLS generates revenue through a blended model: one-time equipment sales across the six diagnostic categories and a recurring reagent/consumable stream (Swelab diluents and lyse, biochemistry reagents such as Glucose GOD-POD, ESR tubes, urine strips) that creates razor-and-blade lock-in on the installed base. Go-to-market is a channel-partner motion executed via 110 distributors, supplemented by continuous medical education (CME) programs, internal QC initiatives, and loyalty programs aimed at mid- and post-sale engagement. The leadership team (Founder & MD Vikas Kothari, Business Head Prem Kumar, Service Head Saravanan) brings 23–26 years of IVD experience each, and the group claims 40+ years of accumulated diagnostics business heritage.

Name

DCLS

Legal name

Diagno Care Life Sciences Pvt. Ltd.

Website

https://dcls.in

Company type

Private

Operating status

Operating

Short description

DCLS (Diagno Care Life Sciences) is a Chennai-based in-vitro diagnostics distributor marketing hematology, biochemistry, critical care, immunoassay, urine, and POCT analyzers across India through 110 distributors, serving 3,000 customers including private hospitals, lab chains, and government facilities with a recurring reagent model.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics

NAICS

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro industry

PRIMARYHLAHAAAM

IVD Reagents, Assay Kits & Consumables (Non-instrument)

Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

SECONDARYHLAGAIAI

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Laboratory Equipment, Instruments & Consumables

SECONDARYHLAHAAAL

Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables)

Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

• In-vitro diagnostics
• Hematology analyzers
• Clinical chemistry analyzers
• Immunoassay systems
• Point-of-care testing

Headquarters

HQ city

Chennai

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Diagnostic Equipment Sales: Sales of in-vitro diagnostic instruments including hematology analyzers, biochemistry analyzers, urine analyzers, critical care analyzers, immunoassay analyzers, and POCT devices
2. Reagent Sales: Sales of配套 reagents for all diagnostic instruments including Swelab reagents (Diluent, Lyse), biochemistry reagents (Glucose GOD-POD), urine strips, and other consumables

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

DCLS markets, distributes, sells, and services in-vitro diagnostic (IVD) analyzers and reagents in six categories—Hematology, Urine Analyzers, Biochemistry, Critical Care, Immunoassay, and POCT—to hospitals, clinical laboratories, diagnostic chains, and government health facilities across India. It combines partner-brand instruments (Boule / Swelab, Snibe Maglumi, Nova Stat Profile, Zybio, Diagnochem) with indigenously manufactured complementary products and bundles LIS/HIS software integration, installation, and after-sales service into the offering.

Product overview

DCLS (Diagno Care Life Sciences) is an in-vitro diagnostics company offering a comprehensive product portfolio spanning six major categories: Hematology (DCH 5600, Swelab Alfa Plus, Swelab Lumi), Urine Analyzers (Zybio UA 3601, DC UA 500, DC UA 100), Biochemistry (Diagno ESR, DC 300, DC 400, Diagnochem DC7, Diagnochem DC), Critical Care (Stat Profile Prime CCS, Stat Profile Prime Plus), Immunoassay (Snibe Maglumi X3, X6, X8), and Point-of-Care Testing (Zybio EXR 110). The company also supplies complementary reagents including Swelab reagents for hematology, liquid stable reagents for biochemistry, and urine strips. Products integrate with Laboratory Information Systems (LIS) and Hospital Information Systems (HIS) via HL7/ASTM protocols. DCLS is authorized by Boule Medical AB (Sweden) to market Swelab hematology products and distributes internationally manufactured analyzers alongside indigenously manufactured offerings, serving institutions, hospitals, laboratory chains, and government healthcare facilities across India.

Differentiator

Problem solved

Functional benefit

Products and services

• Swelab Alfa Plus Hematology Analyzer (3-part differential) Three-part differential fully automated hematology analyzer from Boule Medical AB (Swelab, Sweden), distributed exclusively by DCLS in India for routine CBC testing in small and mid-volume clinical laboratories and hospital labs.
• Swelab Alfa Plus Cap Hematology Analyzer Cap-piercing variant of the Swelab Alfa Plus three-part differential hematology analyzer for closed-vial sampling in hospitals and labs, distributed exclusively by DCLS in India under its Boule Medical AB (Swelab) authorization.
• DCH 5600 Hematology Analyzer (5-part differential) Five-part differential fully automated hematology analyzer marketed by DCLS in India for routine and advanced CBC testing in mid-to-high-volume hospital laboratories and diagnostic chains.
• Hematology Reagents Diluent, lyse and cleaning reagents for routine hematology analyzers, supplied by DCLS to its installed base of Swelab and DCH analyzers across Indian labs and hospitals.
• Zybio UA 3601 Fully Automated Urine Analyzer Fully automated urine chemistry analyzer from Zybio, marketed by DCLS in India for routine urinalysis workloads in hospitals and standalone labs.
• DC UA 500 Fully Automated Urine Analyzer Fully automated urine analyzer in DCLS's own line-up (a complementary indigenously-built/marketed instrument), distributed by DCLS for mid-volume urinalysis in Indian diagnostic laboratories.
• DC UA 100 Semi-Automated Urine Analyzer Semi-automated urine analyzer in DCLS's own line-up, distributed by DCLS in India for low- to mid-volume urinalysis workloads in smaller clinics and labs.
• DC 300 Fully Automated Biochemistry Analyzer Fully automated clinical chemistry analyzer with 300 tests/hour throughput, marketed by DCLS in India for routine biochemistry workloads in mid-volume laboratories.
• DC 400 Fully Automated Biochemistry Analyzer Fully automated clinical chemistry analyzer with 400 tests/hour throughput from Diagnochem, marketed by DCLS in India for mid- to high-volume hospital and reference-laboratory workloads.
• Diagnochem DC7 Biochemistry Analyzer Fully automated random-access clinical chemistry analyzer with closed-reagent system from Diagnochem, distributed by DCLS in India as part of its biochemistry portfolio.
• Diagnochem DC Biochemistry Analyzer Compact fully automated random-access clinical chemistry analyzer from Diagnochem, distributed by DCLS in India for entry-level and small-volume lab use.
• Diagno ESR Automated ESR Analyzer Automated erythrocyte sedimentation rate (ESR) analyzer marketed by DCLS in India for routine inflammation screening in clinical laboratories.
• Biochemistry Reagents Clinical chemistry reagents for routine and specialized assays (liver, kidney, lipid, cardiac, electrolytes, glucose etc.) supplied by DCLS for its installed base of biochemistry analyzers in Indian labs.
• Stat Profile Prime CCS Critical Care Analyzer Cartridge-based blood gas, electrolyte and metabolite critical care analyzer from Nova Biomedical, distributed by DCLS in India for ICU, emergency and point-of-care critical care testing in hospitals.
• Stat Profile Prime Plus Critical Care Analyzer Higher-configuration Nova Biomedical critical care analyzer combining blood gas, electrolytes, metabolites and CO-oximetry, distributed by DCLS for advanced ICUs and emergency departments in Indian hospitals.
• Snibe Maglumi X3 Chemiluminescence Immunoassay Analyzer Compact fully automated chemiluminescence immunoassay (CLIA) analyzer from Snibe, marketed by DCLS in India for low- to mid-volume routine and specialty immunoassay testing.
• Snibe Maglumi X6 Chemiluminescence Immunoassay Analyzer Mid-throughput fully automated chemiluminescence immunoassay (CLIA) analyzer from Snibe, marketed by DCLS in India for mid-volume routine and specialty immunoassay testing in hospitals and labs.
• Snibe Maglumi X8 Chemiluminescence Immunoassay Analyzer High-throughput fully automated chemiluminescence immunoassay (CLIA) analyzer from Snibe, marketed by DCLS in India for high-volume immunoassay workloads in reference laboratories and hospital networks.
• Immunoassay Reagents (CLIA) Chemiluminescence assay kits covering routine hormones, tumor markers, infectious disease, cardiac and other specialty immunoassay parameters, supplied by DCLS for Snibe Maglumi analyzers in India.
• Zybio EXR 110 Point-of-Care Testing (POCT) Analyzer Compact point-of-care testing (POCT) analyzer from Zybio, marketed by DCLS in India for bedside and near-patient testing in hospital wards, ICUs and emergency departments.
• LIS / HIS Software Integration for Diagnostic Analyzers Laboratory Information System (LIS) and Hospital Information System (HIS) integration software/interface delivered by DCLS alongside its analyzers, allowing hospitals to connect diagnostic instruments to their existing IT systems.
• Installation, Application Training and After-Sales Service Bundled installation, application training and ongoing maintenance / breakdown support service for DCLS's installed base of 1,500-plus IVD analyzers across India, delivered by its in-house service team.

Quantifiable outcome

• 18% market share in Hematology achieved within 4 years
• +1 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration10 records

Feature2 records

Partnerships

One partnership is on record.

• Boule Medical AB (Swelab), SwedencoreTechnology or IntegrationDCLS is authorized by Boule Medical AB (Swelab), Sweden to market and provide service to the entire range of Boule hematology products. The company has been successful in expanding Boule hematology against extensive competition, growing market share from 12% to 28% in less than 3 years.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Arkray Healthcare India: India arm of Japanese IVD company specializing in hematology and urine analyzers — directly comparable to DCLS's Swelab and urine analyzer franchises.
• Erba Diagnostics (Trivitron Group): Indian-headquartered IVD brand within Trivitron offering hematology, clinical chemistry, and immunoassay analyzers with a similar mid-market private-hospital go-to-market in India.
• Agappe Diagnostics: Indian IVD manufacturer with strong presence in hematology reagents and biochemistry, competing head-to-head with DCLS for distributor and hospital accounts across Tier-1 and Tier-2 cities.
• Transasia Bio-Medicals: India's largest domestic IVD company with a multi-category hematology, biochemistry, immunoassay, and microbiology portfolio distributed through a wide domestic channel — the most direct competitor to DCLS in Indian hospital and lab markets.
• Tulip Diagnostics (now Perkin Elmer India channel): Kerala-based Indian IVD manufacturer focused on rapid diagnostics, hematology, and biochemistry with a pan-India distribution model closely mirroring DCLS's approach.

Broad incumbents

• Siemens Healthineers India: Indian operations of the global IVD/imaging major; competes with DCLS's hematology, immunoassay, and critical care lines at the top of the Indian market.
• Mindray Bio-Medical India: Indian arm of Chinese IVD major Mindray offering broad hematology, chemistry, immunoassay, and critical care analyzers — a much larger competitor that sells through Indian distributors and increasingly direct channels.
• Roche Diagnostics India: Indian subsidiary of the global IVD leader; competes with DCLS especially in immunoassay, biochemistry, and critical care at the premium end of Indian hospital accounts.

Others

• Snibe (Shenzhen New Industries Biomedical Engineering): Chinese IVD manufacturer of the Maglumi chemiluminescence immunoassay line that DCLS markets in India; a principal/supplier rather than direct competitor, but a comparable IVD company globally.
• Boule Medical AB: Swedish IVD manufacturer whose Swelab hematology line DCLS distributes in India under authorization; included as a peer for context rather than as a competitor, since DCLS is its channel partner.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/watch?v=1gIucr0EtNc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DCLS